{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Valvular+Disease&page=2", "query": { "condition": "Valvular Disease", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Valvular+Disease&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-11T00:06:11.784Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00262600", "title": "Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation", "Stroke" ], "interventions": [ { "name": "warfarin", "type": "DRUG" }, { "name": "Dabigatran dose 1", "type": "DRUG" }, { "name": "Dabigatran dose 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18113, "start_date": "2005-12", "completion_date": null, "has_results": true, "last_update_posted_date": "2019-04-17", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 374, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 286 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00262600" }, { "nct_id": "NCT04281823", "title": "DeBakey Cardiovascular Magnetic Resonance Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiovascular Diseases" ], "interventions": [ { "name": "Cardiovascular Magnetic Resonance", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Dipan Shah", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 100000, "start_date": "2008-04-01", "completion_date": "2058-04-01", "has_results": false, "last_update_posted_date": "2026-04-20", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04281823" }, { "nct_id": "NCT02502396", "title": "Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer", "Deep-vein Thrombosis of the Lower and Upper Extremities", "Pulmonary Embolism", "Non-valvular Atrial Fibrillation" ], "interventions": [ { "name": "Retrospective Chart Review", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 265, "start_date": "2015-09-28", "completion_date": "2022-03-15", "has_results": false, "last_update_posted_date": "2022-03-24", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02502396" }, { "nct_id": "NCT01476995", "title": "Prognostic Indicators as Provided by the EPIC ClearView", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease", "Congestive Heart Failure", "Valvular Heart Disease", "Atrial Fibrillation", "Hypertension", "Pyelonephritis", "Acute Renal Failure", "Renal Failure", "Viral Hepatitis", "Alcoholic Hepatitis", "Steatohepatitis", "Cirrhosis", "Asthma", "COPD", "Bronchitis", "Emphysema", "Pneumonia", "Inflammatory Bowel Disease", "Crohn's Disease", "Ulcerative Colitis", "Diverticulitis", "Peptic Ulcer Disease", "Irritable Bowel Syndrome", "Cholecystitis", "Pancreatitis", "Malabsorption Disorders", "Celiac Sprue", "Diabetes" ], "interventions": [], "intervention_types": [], "sponsor": "Epic Research & Diagnostics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 353, "start_date": "2010-09", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2011-11-22", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01476995" }, { "nct_id": "NCT05666713", "title": "NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Valvular Heart Disease", "Aortic Valve Failure" ], "interventions": [ { "name": "TELLTALE BASILICA procedure", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "109 Years", "sex": "ALL", "summary": "21 Years to 109 Years" }, "enrollment_count": 90, "start_date": "2023-02-21", "completion_date": "2025-04-25", "has_results": true, "last_update_posted_date": "2026-02-03", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 10, "location_summary": "San Francisco, California • Fort Collins, Colorado • Washington D.C., District of Columbia + 7 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05666713" }, { "nct_id": "NCT03935178", "title": "Evaluating Right Ventricular (RV) Size and Function Using the Upper Valley RV Algorithm and Novel Imaging Modalities", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Hypertension", "Valvular Heart Disease", "Congenital Heart Disease", "Congestive Heart Failure", "Pulmonary Embolism", "Acute Coronary Syndrome" ], "interventions": [ { "name": "Measuring Right Ventricular Size and Function", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2019-08-05", "completion_date": "2022-01-30", "has_results": false, "last_update_posted_date": "2022-04-06", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 1, "location_summary": "Lebanon, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT03935178" }, { "nct_id": "NCT02561897", "title": "EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "Edoxaban", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Electrophysiology Research Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2015-12", "completion_date": "2017-12", "has_results": true, "last_update_posted_date": "2020-06-30", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 1, "location_summary": "Warren Township, New Jersey", "locations": [ { "city": "Warren Township", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02561897" }, { "nct_id": "NCT04509193", "title": "A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "Rivaroxaban (Xarelto, BAY59-7939)", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 116049, "start_date": "2020-08-21", "completion_date": "2021-07-31", "has_results": false, "last_update_posted_date": "2022-06-15", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 1, "location_summary": "Whippany, New Jersey", "locations": [ { "city": "Whippany", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04509193" }, { "nct_id": "NCT03473223", "title": "Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Coronary Syndrome" ], "interventions": [ { "name": "Apolipoprotein A-I [human] (apoA-I)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "CSL Behring", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18226, "start_date": "2018-03-21", "completion_date": "2023-11-17", "has_results": true, "last_update_posted_date": "2025-01-14", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 202, "location_summary": "Alexander City, Alabama • Birmingham, Alabama • Huntsville, Alabama + 175 more", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03473223" }, { "nct_id": "NCT00530894", "title": "THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Critical Aortic Stenosis" ], "interventions": [ { "name": "Edwards SAPIEN Transcatheter Heart Valve", "type": "DEVICE" }, { "name": "Surgical Valve Replacement", "type": "DEVICE" }, { "name": "medical management and/or balloon aortic valvuloplasty", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Edwards Lifesciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1057, "start_date": "2007-04", "completion_date": "2017-07", "has_results": true, "last_update_posted_date": "2017-09-13", "last_synced_at": "2026-06-11T00:06:11.784Z", "location_count": 22, "location_summary": "La Jolla, California • Los Angeles, California • Stanford, California + 17 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00530894" } ] }